In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

July 13, 2020
'Unfounded Attacks' On Opioid Judge Must Fail, 6th Circ. Told

CVS Pharmacy Inc., Walgreen Co. and other national pharmacy chains are making phony bias allegations against the Ohio federal judge overseeing multidistrict opioid litigation because they're upset about having lost several legal arguments, local governments have told the Sixth Circuit.
July 07, 2020
Bias Charge Is 'Dangerous Fiction,' Opioid MDL Judge Says

The Ohio federal judge overseeing multidistrict opioid litigation lambasted Walgreen Co., CVS Health Corp. and other pharmacy giants Tuesday for seeking his disqualification from the sprawling MDL, telling the Sixth Circuit that allegations of bias are reckless and untrue.
July 07, 2020
Amerisource Tries To Save CEO From Opioid Bellwether Depo

AmerisourceBergen Drug Corp. has urged a West Virginia federal judge to undo a special master's order that its CEO testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, arguing that the ruling opens the floodgates to "limitless" depositions of the executive.
July 06, 2020
Pharmacies Can't Slip Opioid Nuisance Claims, Counties Say

Two Ohio counties urged a federal judge to shut down requests by pharmacy chains to toss claims that they created a public nuisance by failing to monitor suspicious opioid orders that helped fuel an epidemic of painkiller addiction, saying the state's public nuisance law fits their claims.
June 30, 2020
Pharmacies Urge 6th Circ. To Boot Opioid MDL Judge

CVS Health Corp., Walgreen Co. and other major pharmacy chains asked the Sixth Circuit on Tuesday to disqualify the Ohio federal judge supervising multidistrict opioid litigation, accusing him of exhibiting blatant bias by "directing plaintiffs' trial strategy."
June 29, 2020
AmerisourceBergen CEO Must Testify In Opioid Bellwether

Virginia Special Master Christopher C. Wilkes on Monday ordered AmerisourceBergen Drug Corp. CEO Steven H. Collis to testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, rejecting the company's arguments taking his video-deposition would be too burdensome.
June 23, 2020
Chicago Says Drug Cos. Shouldn't Exit Opioid Bellwether Suit

Johnson & Johnson and Teva Pharmaceuticals can't escape a Chicago bellwether case over their allegedly deceptive opioid marketing because earlier rulings have already largely upheld the allegations, the city argued Monday.
June 17, 2020
Pharmacies Want Out Of Opioid MDL 'Public Nuisance' Suits

A group of pharmacies is asking an Ohio federal judge to dismiss complaints by two Ohio counties alleging the pharmacies contributed to the opioid epidemic, saying the counties are suing under public nuisance laws that don't fit their claims.
June 15, 2020
Pharmacies Can't Avoid Common Discovery In Opioid MDL

An Ohio federal judge on Monday rejected a bid by pharmacies involved in the sprawling opioid multidistrict litigation to rescind a ruling forcing them to put discovery documents into a common repository, saying the ruling aligns with the purposes of an MDL and imposes "virtually zero" burden on the companies.
June 12, 2020
Cherokee Nation Fights Bid To Nix Opioid Bellwether

The Cherokee Nation asked an Oklahoma federal judge Thursday to reject a bid by major drug distributors and pharmacies to toss the tribe's suit alleging they created the opioid crisis that has harmed it, saying their arguments for dismissal have already been rejected in vast opioid multidistrict litigation centralized in Ohio federal court.

← Previous
…
24
25
26
27
28
29
30
31
32
…
Next →